CytomX inks potential $348 million cancer-fighting deal with Bristol-Myers Squibb
May 27, 2014 at 08:43 AM EDT
CytomX Therapeutics Inc. will get $50 million upfront from Bristol-Myers Squibb Co. in a research and licensing deal centered on a next generation of antibodies designed to rally the immune system to fight cancer...
